Abstract

Genetic testing for Parkinson’s disease (PD) is increasing globally, and genetic counseling is an important service that provides information and promotes understanding about PD genetics and genetic testing. PD research studies have initiated outreach to underrepresented regions in North America, including regions in Latin America, such as the Dominican Republic (DR); some studies may include return of genetic test results. Thus, understanding what individuals know about PD, genetic testing for PD, and their interest in speaking with a genetic counselor, is crucial when assessing readiness. In this cross-sectional study, a survey was distributed to people with Parkinson’s disease (PwP) and their unaffected biological relatives in the DR. Questions assessed genetics knowledge, attitude toward genetic testing, and interest in genetic testing and counseling. Of 45 participants, 69% scored the maximum on the attitude scale, indicating an overall positive attitude toward genetic testing; 95% indicated interest in genetic testing for PD, and 98% were at least somewhat interested in meeting with a genetic counselor. The mean PD genetics knowledge score was similar to previously published data. Through free text responses, participants expressed a desire to know more about PD treatment and management, prevention, cause, and their personal risk for PD. These results provide further evidence of readiness for genetic testing in this country but also underscore some gaps in knowledge that should be addressed with targeted educational efforts, as part of building genetic testing and counseling capacities.

Details

Title
Readiness for Parkinson’s disease genetic testing and counseling in patients and their relatives in urban settings in the Dominican Republic
Author
Hackl, Margaret 1   VIAFID ORCID Logo  ; Cook, Lola 2 ; Wetherill, Leah 2   VIAFID ORCID Logo  ; Walsh, Laurence E. 3 ; Delk, Paula 2   VIAFID ORCID Logo  ; De León, Rebeca 4 ; Carbonell, Janfreisy 5 ; Vicioso, Rossy Cruz 5 ; Hodges, Priscila Delgado 2   VIAFID ORCID Logo 

 Indiana University School of Medicine, Department of Medical and Molecular Genetics, Indianapolis, USA (GRID:grid.257413.6) (ISNI:0000 0001 2287 3919); Medical College of Wisconsin, Department of Obstetrics and Gynecology, Milwaukee, USA (GRID:grid.30760.32) (ISNI:0000 0001 2111 8460) 
 Indiana University School of Medicine, Department of Medical and Molecular Genetics, Indianapolis, USA (GRID:grid.257413.6) (ISNI:0000 0001 2287 3919) 
 Indiana University School of Medicine, Department of Medical and Molecular Genetics, Indianapolis, USA (GRID:grid.257413.6) (ISNI:0000 0001 2287 3919); Indiana University School of Medicine, Department of Neurology, Section of Child Neurology, Indianapolis, USA (GRID:grid.257413.6) (ISNI:0000 0001 2287 3919); Indiana University School of Medicine, Department of Pediatrics, Indianapolis, USA (GRID:grid.257413.6) (ISNI:0000 0001 2287 3919) 
 Parkinson’s Foundation, New York, USA (GRID:grid.453428.c) (ISNI:0000 0001 2236 2879) 
 Centro Cardio-Neuro-Oftalmológico y Trasplante (CECANOT), Santo Domingo, Dominican Republic (GRID:grid.453428.c) 
Pages
126
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
23738057
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2858510113
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.